Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 166-176
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.166
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.166
Figure 4 Histopathology and immunohistochemistry of localized lesions of chronic eczema to intralesional treatment with 5-FU+TA and TA before and 2 wk after treatment.
(A) Representative histologic images of biopsy specimens from localized lesions of chronic eczema were collected before and at 2 wk after treatment. Tissue samples (n = 15 for each group) were stained with HE and antibodies against CD4, CD8, or CD103 to detect T-cell infiltration in the lesional skin. (B) CD4+, CD8+, and CD103+ T cell counts were quantified in high-power field images of lesions biopsied before and 2 wk after treatment. Blue points: 5-FU + TA group; Red points: TA group. aP < 0.05, bP < 0.01. 5-FU, 5-fluorouracil; TA, triamcinolone.
- Citation: Wu Y, Wang GJ, He HQ, Qin HH, Shen WT, Yu Y, Zhang X, Zhou ML, Fei JB. Low-dose intralesional injection of 5-fluorouracil and triamcinolone reduces tissue resident memory T cells in chronic eczema. World J Clin Cases 2022; 10(1): 166-176
- URL: https://www.wjgnet.com/2307-8960/full/v10/i1/166.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i1.166